Pandemic preparedness beyond COVID-19

Investing in vaccines production and supply for LMICs
in partnership with the World Health Organization (WHO)
Event
Session Type
Conference
Room number
WIF Virtual Platform, room 8
Event Manager
Mr. Ermias Biadgleng
Contact Email
Ermias.Biadgleng@unctad.org
Background Documents
21 October 2021
09:30 - 11:00 Europe/Zurich
Europe/Zurich
Session video
Pandemic Preparedness Beyond COVID-19: Investing in vaccines production and supply for Low and Middle-Income Countries (in partnership with WHO)

The current pandemic has highlighted the exposure of LMICs to global vaccine supply shortages, despite efforts by the industry to increase manufacturing capacity, including in large developing countries. This challenge extends well beyond COVID-19. Routine vaccination programs need to be maintained in LMICs to avoid increased mortality, especially among children. Building productive capacity in developing countries for vaccines beyond COVID-19 could make an important contribution to equitable access and pandemic preparedness in LMICs. Increased global cooperation is essential to achieve this goal.

At a World Investment Forum satellite event on 3 March 2021, UNCTAD in partnership with WHO launched a series of consultations with policymakers, investors, vaccine manufacturers and technology providers on how to coordinate and promote investment in LMIC-based vaccine productive capacity. The event involved major actors in the international COVID-19 response such as, inter alia, the Coalition for Epidemic Preparedness Innovations, International Finance Corporation, Bill & Melinda Gates Foundation, African Development Bank and Serum Institute of India. The purpose of this event is to report on these consultations, take stock of partnerships to date and discuss the way forward in intensifying partnerships for vaccine productive capacity.

Sessions:

  1. Presentation: Key development on partnership for production of vaccines in LMICs
  2. Roundtable discussion: Taking stock of the status of partnership for production of vaccines in LMICs and the way forward
  3. Commentary and discussion: Status of partnership for production of vaccines in LMICs and the way forward

Speakers

Deputy Secretary-General, United Nations Conference on Trade and Development
Director, Regulation and Prequalification Department, Access to Medicines and Health Products Division, World Health Organization
Deputy Director-General, Directorate-General for International Partnerships, Responsible for Directorates G and R, European Commission
Senior Science Advisor to the Africa CDC Director
Sustainable Manufacturing Lead, Coalition for Epidemic Preparedness Innovations
Executive Director, African Vaccine Manufacturing Initiative
Director Industry and Trade Development Department, AfDB
Deputy Director, CMC Vaccines Development and Surveillance, Bill & Melinda Gates Foundation
Director Economic and Social Development, Digitalization Sector and Global Programmes, Deutsche Gesellschaft für Internationale Zusammenarbeit
Director, Regional Integration and Trade Division, United Nations Economic Commission for Africa

Moderators

Head, Local Production and Assistance Unit, Regulation and Prequalification Department, Access to Medicines and Health Products Division, World Health Organisation